Cargando…

Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucio, Marianna, Willkommen, Desiree, Schroeter, Michael, Sigaroudi, Ali, Schmitt-Kopplin, Philippe, Michalke, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908950/
https://www.ncbi.nlm.nih.gov/pubmed/31866853
http://dx.doi.org/10.3389/fnagi.2019.00331
_version_ 1783478848543784960
author Lucio, Marianna
Willkommen, Desiree
Schroeter, Michael
Sigaroudi, Ali
Schmitt-Kopplin, Philippe
Michalke, Bernhard
author_facet Lucio, Marianna
Willkommen, Desiree
Schroeter, Michael
Sigaroudi, Ali
Schmitt-Kopplin, Philippe
Michalke, Bernhard
author_sort Lucio, Marianna
collection PubMed
description Parkinson’s disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites and metallomic data, in this research, we combined a control study measured using two different platforms. For the different data sources, we applied a Block Sparse Partial Least Square Discriminant Analysis (Block-sPLS-DA) model that allows for proving their relation, which in turn uncovers alternative influencing factors that remain hidden otherwise. We found two groups of variables that trace a strong relationship between metallomic and metabolomic parameters for disease development. The results confirmed that the redox active metals iron (Fe) and copper (Cu) together with fatty acids are the major influencing factors for the PD. Additionally, the metabolic waste product p-cresol sulfate and the trace element nickel (Ni) showed up as potentially important factors in PD. In summary, the data integration of different types of measurements emphasized the results of both stand-alone measurements providing a new comprehensive set of information and interactions, on PD disease, between different variables sources.
format Online
Article
Text
id pubmed-6908950
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69089502019-12-20 Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease Lucio, Marianna Willkommen, Desiree Schroeter, Michael Sigaroudi, Ali Schmitt-Kopplin, Philippe Michalke, Bernhard Front Aging Neurosci Neuroscience Parkinson’s disease (PD) is a neurodegenerative disease with a complex etiology. Several factors are known to contribute to the disease onset and its progression. However, the complete underlying mechanisms are still escaping our understanding. To evaluate possible correlations between metabolites and metallomic data, in this research, we combined a control study measured using two different platforms. For the different data sources, we applied a Block Sparse Partial Least Square Discriminant Analysis (Block-sPLS-DA) model that allows for proving their relation, which in turn uncovers alternative influencing factors that remain hidden otherwise. We found two groups of variables that trace a strong relationship between metallomic and metabolomic parameters for disease development. The results confirmed that the redox active metals iron (Fe) and copper (Cu) together with fatty acids are the major influencing factors for the PD. Additionally, the metabolic waste product p-cresol sulfate and the trace element nickel (Ni) showed up as potentially important factors in PD. In summary, the data integration of different types of measurements emphasized the results of both stand-alone measurements providing a new comprehensive set of information and interactions, on PD disease, between different variables sources. Frontiers Media S.A. 2019-12-06 /pmc/articles/PMC6908950/ /pubmed/31866853 http://dx.doi.org/10.3389/fnagi.2019.00331 Text en Copyright © 2019 Lucio, Willkommen, Schroeter, Sigaroudi, Schmitt-Kopplin and Michalke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Lucio, Marianna
Willkommen, Desiree
Schroeter, Michael
Sigaroudi, Ali
Schmitt-Kopplin, Philippe
Michalke, Bernhard
Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
title Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
title_full Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
title_fullStr Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
title_full_unstemmed Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
title_short Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
title_sort integrative metabolomic and metallomic analysis in a case–control cohort with parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908950/
https://www.ncbi.nlm.nih.gov/pubmed/31866853
http://dx.doi.org/10.3389/fnagi.2019.00331
work_keys_str_mv AT luciomarianna integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease
AT willkommendesiree integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease
AT schroetermichael integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease
AT sigaroudiali integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease
AT schmittkopplinphilippe integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease
AT michalkebernhard integrativemetabolomicandmetallomicanalysisinacasecontrolcohortwithparkinsonsdisease